Rao, Lubei
Hu, Chao
Yue, Yan
Luo, Yajun
Ye, Bo
Liang, Yue
Zhang, Guanbin
Wang, Dongsheng
Funding for this research was provided by:
Natural Science Foundation of Sichuan Province (2024NSFSC1880)
National Natural Science Foundation of China (82302993)
Article History
Received: 13 July 2025
Accepted: 18 September 2025
First Online: 11 November 2025
Declarations
:
: The authors declare no competing interests.
: The research related to human use has complied with all the relevant national regulations, institutional policies and follows the tenets of the Helsinki Declaration, and has been approved by the Institutional Ethics Committee of The Sichuan Cancer Hospital (IRB No. SCCHEC-02–2022-017).
: The study was exempted from informed consent (IRB No. SCCHEC-02–2022-017).
: Not applicable.